Lynn Dee Silver
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Lynn Dee Silver has a total of 179 co-authors. Here are the top co-authors by number of shared publications:
- Alisa A. Padon
Public Health Institute Oakland CA USA
7 shared publications Mary T. Bassett
7 shared publicationsJoslyn Levy
At the time this article was written, all authors were with the Bureau of Chronic Disease Prevention and Control, New York City Department of Health and Mental Hygiene, New York, NY
5 shared publicationsTamara Dumanovsky
5 shared publications- Thomas R. Frieden
Resolve to Save Lives, New York, NY, USA
4 shared publications - Aurash J. Soroosh
Public Health Institute, Oakland, CA, USA
3 shared publications
Latest Publications
- Open Access
- 12 September 2026
- Published by Elsevier in International Journal of Drug Policy
- Vol. 157
Observational study: Sales of Cannabis with flavor-indicating names by purchaser age in California 2020–2021
- 12 September 2026
- Published by Elsevier in International Journal of Drug Policy
- Vol. 157
Open AccessObservational study: Sales of Cannabis with flavor-indicating names by purchaser age in California 2020–2021
Adolescent cannabis use disorder following recreational cannabis legalization in California, USA: A population‐based interrupted time series study
Aims: To examine whether and how rates of adolescent cannabis use disorder (CUD) in California, USA, changed after recreational cannabis legalization (RCL). Design and setting: Population‐based time‐series study of adolescents aged 13 to 17 years with Kaiser Permanente Northern California healthcare system membership from January 2014 to February 2020. Participants: The sample ( n = 637 461) was 66.45% non‐White, 50.93% male, with a mean (standard deviation) age of 14.07 (1.43) years. Measurements: Exposure variables included California state RCL passage (9 November 2016), which legalized possession, home grows and reduced penalties for underage possession; and implementation of legal recreational sales (1 January 2018). Outcome was the count of incident CUD diagnoses in each month, extracted from the electronic health record. Interrupted time series analyses were fit using Poisson regression. Results: In the best fitting model, prior to RCL passage, CUD rates were decreasing [adjusted rate ratio (aRR) = 0.95 per year, 95% confidence interval (CI) = 0.92–0.97]. Rates increased at the time of RCL passage + 6‐month lag (adjusted slope change aRR = 1.26, 95% CI = 1.14–1.38). At RCL implementation + 6 months, there was a statistically significant negative slope change (adjusted slope change aRR = 0.86, 95% CI = 0.76–0.98). CUD incidence continued to increase, but was no longer statistically significant (adjusted trend aRR = 1.02, 95% CI = 0.96–1.09). Summary: Among adolescents in Northern California, USA, trends in incident cannabis use disorder rates appeared to increase following recreational cannabis legalization passage, with increasing rates persisting through retail implementation and three years post‐passage. Results underscore the importance of monitoring cannabis use disorder, in addition to measures of cannabis use prevalence and frequency, when evaluating the public health implications of cannabis legalization.
Adolescent cannabis use disorder following recreational cannabis legalization in California, USA: A population‐based interrupted time series study
Aims: To examine whether and how rates of adolescent cannabis use disorder (CUD) in California, USA, changed after recreational cannabis legalization (RCL). Design and setting: Population‐based time‐series study of adolescents aged 13 to 17 years with Kaiser Permanente Northern California healthcare system membership from January 2014 to February 2020. Participants: The sample ( n = 637 461) was 66.45% non‐White, 50.93% male, with a mean (standard deviation) age of 14.07 (1.43) years. Measurements: Exposure variables included California state RCL passage (9 November 2016), which legalized possession, home grows and reduced penalties for underage possession; and implementation of legal recreational sales (1 January 2018). Outcome was the count of incident CUD diagnoses in each month, extracted from the electronic health record. Interrupted time series analyses were fit using Poisson regression. Results: In the best fitting model, prior to RCL passage, CUD rates were decreasing [adjusted rate ratio (aRR) = 0.95 per year, 95% confidence interval (CI) = 0.92–0.97]. Rates increased at the time of RCL passage + 6‐month lag (adjusted slope change aRR = 1.26, 95% CI = 1.14–1.38). At RCL implementation + 6 months, there was a statistically significant negative slope change (adjusted slope change aRR = 0.86, 95% CI = 0.76–0.98). CUD incidence continued to increase, but was no longer statistically significant (adjusted trend aRR = 1.02, 95% CI = 0.96–1.09). Summary: Among adolescents in Northern California, USA, trends in incident cannabis use disorder rates appeared to increase following recreational cannabis legalization passage, with increasing rates persisting through retail implementation and three years post‐passage. Results underscore the importance of monitoring cannabis use disorder, in addition to measures of cannabis use prevalence and frequency, when evaluating the public health implications of cannabis legalization.
- 12 May 2026
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 71 (4) , 108411
Trends in Cannabis Retailer Density and Proximity to Pregnant Individuals in California, 2018–2024
- 12 May 2026
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 71 (4) , 108411
Trends in Cannabis Retailer Density and Proximity to Pregnant Individuals in California, 2018–2024
- 10 February 2025
- Published by Elsevier in International Journal of Drug Policy
- Vol. 137, 104718
Characteristics and effects of cannabis advertisements with appeal to youth in California
- 10 February 2025
- Published by Elsevier in International Journal of Drug Policy
- Vol. 137, 104718
Characteristics and effects of cannabis advertisements with appeal to youth in California
- Open Access
- 16 January 2025
- Published by Oxford University Press (OUP) in Translational Behavioral Medicine
- Vol. 15 (1)
Assessing barriers to community engagement on cannabis policy: baseline survey of behavioral and public health professionals in California
Background: Cannabis policy is a complex and rapidly evolving topic with significant implications for behavioral and public health. Behavioral and public health professionals have an opportunity to identify emerging problems, engage with communities to identify solutions and work to educate and guide policymakers to support cannabis policies that benefit public health. However, little is known about their engagement in cannabis policy. Methods: A 2023 survey assessed barriers to community engagement on cannabis policy among a broad sample of behavioral and public health professionals throughout California. Professionals in behavioral health, substance use, public health, tobacco control, and youth prevention were invited. Results: Responses were received from 246 people (44% response rate) working in three main sectors (50% nonprofit, 34% government, and 13% health care) and each of California’s 58 counties. Seventy percent of respondents reported they were interested in being involved in cannabis regulation. However, only 34% had ever worked in cannabis policy. They encountered structural barriers: restrictions on lobbying (38%), funding availability (38%), and staff time (34%). They also reported motivational barriers: few had confidence working on specific cannabis policy issues, including taxation policies (20%) and restricting intoxicating hemp products (29%); few were comfortable with certain community engagement activities, such as writing laws or policies (20%) or preparing written comments on proposed laws (31%). They reported their engagement would benefit most from additional financial resources (70%), training (59%), political support (48%), model laws (42%), and technical assistance (40%). Conclusion: Behavioral and public health professionals have limited experience with engagement in cannabis policy issues. They face structural and motivational barriers. They need dedicated resources and support for their work. These findings may be relevant to advancing community engagement in cannabis in other states and countries.
- 16 January 2025
- Published by Oxford University Press (OUP) in Translational Behavioral Medicine
- Vol. 15 (1)
Open AccessAssessing barriers to community engagement on cannabis policy: baseline survey of behavioral and public health professionals in California
Background: Cannabis policy is a complex and rapidly evolving topic with significant implications for behavioral and public health. Behavioral and public health professionals have an opportunity to identify emerging problems, engage with communities to identify solutions and work to educate and guide policymakers to support cannabis policies that benefit public health. However, little is known about their engagement in cannabis policy. Methods: A 2023 survey assessed barriers to community engagement on cannabis policy among a broad sample of behavioral and public health professionals throughout California. Professionals in behavioral health, substance use, public health, tobacco control, and youth prevention were invited. Results: Responses were received from 246 people (44% response rate) working in three main sectors (50% nonprofit, 34% government, and 13% health care) and each of California’s 58 counties. Seventy percent of respondents reported they were interested in being involved in cannabis regulation. However, only 34% had ever worked in cannabis policy. They encountered structural barriers: restrictions on lobbying (38%), funding availability (38%), and staff time (34%). They also reported motivational barriers: few had confidence working on specific cannabis policy issues, including taxation policies (20%) and restricting intoxicating hemp products (29%); few were comfortable with certain community engagement activities, such as writing laws or policies (20%) or preparing written comments on proposed laws (31%). They reported their engagement would benefit most from additional financial resources (70%), training (59%), political support (48%), model laws (42%), and technical assistance (40%). Conclusion: Behavioral and public health professionals have limited experience with engagement in cannabis policy issues. They face structural and motivational barriers. They need dedicated resources and support for their work. These findings may be relevant to advancing community engagement in cannabis in other states and countries.
- 3 August 2024
- Published by Elsevier in International Journal of Drug Policy
- Vol. 131, 104542
Racial, ethnic, and neighborhood socioeconomic disparities in local cannabis retail policy in California
- 3 August 2024
- Published by Elsevier in International Journal of Drug Policy
- Vol. 131, 104542
Racial, ethnic, and neighborhood socioeconomic disparities in local cannabis retail policy in California
- Open Access
- 25 January 2023
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 3 (1) , e0001219
Changes in sugar-sweetened beverage consumption in the first two years (2018 – 2020) of San Francisco’s tax: A prospective longitudinal study
Background: Sugar sweetened beverage (SSB) taxes are a promising strategy to decrease SSB consumption, and their inequitable health impacts, while raising revenue to meet social objectives. In 2016, San Francisco passed a one cent per ounce tax on SSBs. This study compared SSB consumption in San Francisco to that in San José, before and after tax implementation in 2018. Methods & findings: A longitudinal panel of adults (n = 1,443) was surveyed from zip codes in San Francisco and San José, CA with higher densities of Black and Latino residents, racial/ethnic groups with higher SSB consumption in California. SSB consumption was measured at baseline (11/17-1/18), one- (11/18-1/19), and two-years (11/19-1/20) after the SSB tax was implemented in January 2018. Average daily SSB consumption (in ounces) was ascertained using the BevQ-15 instrument and modeled as both continuous and binary (high consumption: ≥6 oz (178 ml) versus low consumption: <6 oz) daily beverage intake measures. Weighted generalized linear models (GLMs) estimated difference-in-differences of SSB consumption between cities by including variables for year, city, and their interaction, adjusting for demographics and sampling source. In San Francisco, average SSB consumption in the sample declined by 34.1% (-3.68 oz, p = 0.004) from baseline to 2 years post-tax, versus San José which declined 16.5% by 2 years post-tax (-1.29 oz, p = 0.157), a non-significant difference-in-differences (-17.6%, adjusted AMR = 0.79, p = 0.224). The probability of high SSB intake in San Francisco declined significantly more than in San José from baseline to 2-years post-tax (AOR[interaction] = 0.49, p = 0.031). The difference-in-differences of odds of high consumption, examining the interaction between cities, time and poverty, was far greater (AOR[city*year 2*federal poverty level] = 0.12, p = 0.010) among those living below 200% of the federal poverty level 2-years post-tax. Conclusions: Average SSB intake declined significantly in San Francisco post-tax, but the difference in differences between cities over time did not vary significantly. Likelihood of high SSB intake declined significantly more in San Francisco by year 2 and more so among low-income respondents.
- 25 January 2023
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 3 (1) , e0001219
Open AccessChanges in sugar-sweetened beverage consumption in the first two years (2018 – 2020) of San Francisco’s tax: A prospective longitudinal study
Background: Sugar sweetened beverage (SSB) taxes are a promising strategy to decrease SSB consumption, and their inequitable health impacts, while raising revenue to meet social objectives. In 2016, San Francisco passed a one cent per ounce tax on SSBs. This study compared SSB consumption in San Francisco to that in San José, before and after tax implementation in 2018. Methods & findings: A longitudinal panel of adults (n = 1,443) was surveyed from zip codes in San Francisco and San José, CA with higher densities of Black and Latino residents, racial/ethnic groups with higher SSB consumption in California. SSB consumption was measured at baseline (11/17-1/18), one- (11/18-1/19), and two-years (11/19-1/20) after the SSB tax was implemented in January 2018. Average daily SSB consumption (in ounces) was ascertained using the BevQ-15 instrument and modeled as both continuous and binary (high consumption: ≥6 oz (178 ml) versus low consumption: <6 oz) daily beverage intake measures. Weighted generalized linear models (GLMs) estimated difference-in-differences of SSB consumption between cities by including variables for year, city, and their interaction, adjusting for demographics and sampling source. In San Francisco, average SSB consumption in the sample declined by 34.1% (-3.68 oz, p = 0.004) from baseline to 2 years post-tax, versus San José which declined 16.5% by 2 years post-tax (-1.29 oz, p = 0.157), a non-significant difference-in-differences (-17.6%, adjusted AMR = 0.79, p = 0.224). The probability of high SSB intake in San Francisco declined significantly more than in San José from baseline to 2-years post-tax (AOR[interaction] = 0.49, p = 0.031). The difference-in-differences of odds of high consumption, examining the interaction between cities, time and poverty, was far greater (AOR[city*year 2*federal poverty level] = 0.12, p = 0.010) among those living below 200% of the federal poverty level 2-years post-tax. Conclusions: Average SSB intake declined significantly in San Francisco post-tax, but the difference in differences between cities over time did not vary significantly. Likelihood of high SSB intake declined significantly more in San Francisco by year 2 and more so among low-income respondents.
- 3 October 2022
- Published by Taylor & Francis in Journal of Health Communication
- Vol. 27 (10) , 717-726
Yet Again Conversations Matter: The Importance of Interpersonal Discussions, Educational Campaigns, and Advertising on Cannabis-Related Risk Perceptions, Attitudes, and Intentions in At-Risk Young Adults
The present study seeks to evaluate the relationships between cannabis-related communication and outcomes of interest such as cannabis-related risk perceptions, attitudes, and behaviors among young adults. Young adults who were at risk for cannabis use were surveyed online in 2020. Results showed that exposure to online educational messages was associated with higher intentions of engaging in peer intervention, while exposure to online advertising was related to higher intention to use cannabis. Anti-cannabis interpersonal discussion was associated with increased risk perceptions, less favorable cannabis attitudes, and a higher likelihood of peer intervention. More pro-cannabis interpersonal discussion was associated with decreased risk perceptions, more favorable cannabis attitudes, higher use intention, and decreased likelihood of peer intervention. In addition, pro-cannabis interpersonal discussion mediated the relationship between exposure to advertising and cannabis risk perceptions, intentions to use cannabis, attitudes about cannabis, and the likelihood of peer intervention. In contrast, anti-cannabis interpersonal discussion mediated the relationship between exposure to educational messages online and cannabis risk perceptions and the likelihood of peer intervention. These findings underscore the need to regulate online cannabis marketing and the importance of investing in online education campaigns to increase public understanding of the risks associated with cannabis consumption in young adulthood.
- 3 October 2022
- Published by Taylor & Francis in Journal of Health Communication
- Vol. 27 (10) , 717-726
Yet Again Conversations Matter: The Importance of Interpersonal Discussions, Educational Campaigns, and Advertising on Cannabis-Related Risk Perceptions, Attitudes, and Intentions in At-Risk Young Adults
The present study seeks to evaluate the relationships between cannabis-related communication and outcomes of interest such as cannabis-related risk perceptions, attitudes, and behaviors among young adults. Young adults who were at risk for cannabis use were surveyed online in 2020. Results showed that exposure to online educational messages was associated with higher intentions of engaging in peer intervention, while exposure to online advertising was related to higher intention to use cannabis. Anti-cannabis interpersonal discussion was associated with increased risk perceptions, less favorable cannabis attitudes, and a higher likelihood of peer intervention. More pro-cannabis interpersonal discussion was associated with decreased risk perceptions, more favorable cannabis attitudes, higher use intention, and decreased likelihood of peer intervention. In addition, pro-cannabis interpersonal discussion mediated the relationship between exposure to advertising and cannabis risk perceptions, intentions to use cannabis, attitudes about cannabis, and the likelihood of peer intervention. In contrast, anti-cannabis interpersonal discussion mediated the relationship between exposure to educational messages online and cannabis risk perceptions and the likelihood of peer intervention. These findings underscore the need to regulate online cannabis marketing and the importance of investing in online education campaigns to increase public understanding of the risks associated with cannabis consumption in young adulthood.
- 6 June 2022
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 237, 109520
Textual and pictorial enhancement of cannabis warning labels: An Online experiment among at-risk U.S. young adults
- 6 June 2022
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 237, 109520
Textual and pictorial enhancement of cannabis warning labels: An Online experiment among at-risk U.S. young adults
- 1 June 2020
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 3 (6) , e208393
Assessment of Incorporation of Lessons From Tobacco Control in City and County Laws Regulating Legal Marijuana in California
Marijuana continues to be legalized in many states, generally with limited public health input. Although valid medicinal applications exist, the National Academies of Science, Engineering, and Medicine concluded that substantial evidence suggests that marijuana use is also associated with significant harms, including psychosis, schizophrenia, problem marijuana use, motor vehicle collisions, low birth weight, and respiratory symptoms.1 Evidence is emerging regarding the association of marijuana use with youths’ cognition2,3 and cardiovascular disease,4-6 as well as other areas, and the 2019 vaping epidemic demonstrated the hazards of rapid product innovation without due evaluation of safety.7 With widespread lifetime and adolescent use of marijuana, reaching 43.6% of 12th-grade students nationally,8 and 51.5% of 18- to 25-year-olds in 2018,9 even modest increases in risk may have a significant effect on population health. Vaping of marijuana in the past 30 days, which typically involves high-potency concentrates, increased from 5% of 12th-grade students in 2017 to 14% in 2019, with 3.5% vaping near daily in 2019.10 The potential magnitude of mental health effects associated with the growing market of high-potency marijuana products is evidenced by estimates of the population-attributable fraction of first-episode psychosis due to use of high-potency marijuana (>10% tetrahydrocannabinol [THC]) at 12% (range, 1.9%-50.3%) in 11 primarily European cities studied, and by elevated risk for first-episode psychosis found in individuals using these products daily.11 Treatment data also suggest reason for concern. In 2014, marijuana was the leading drug used by clients entering drug treatment in a study of 22 European countries, representing 46% of all new clients, up from 29% in 2003.12 Both marijuana-related new clients and daily users in treatment more than doubled between 2003 and 2014.
- 1 June 2020
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 3 (6) , e208393
Assessment of Incorporation of Lessons From Tobacco Control in City and County Laws Regulating Legal Marijuana in California
Marijuana continues to be legalized in many states, generally with limited public health input. Although valid medicinal applications exist, the National Academies of Science, Engineering, and Medicine concluded that substantial evidence suggests that marijuana use is also associated with significant harms, including psychosis, schizophrenia, problem marijuana use, motor vehicle collisions, low birth weight, and respiratory symptoms.1 Evidence is emerging regarding the association of marijuana use with youths’ cognition2,3 and cardiovascular disease,4-6 as well as other areas, and the 2019 vaping epidemic demonstrated the hazards of rapid product innovation without due evaluation of safety.7 With widespread lifetime and adolescent use of marijuana, reaching 43.6% of 12th-grade students nationally,8 and 51.5% of 18- to 25-year-olds in 2018,9 even modest increases in risk may have a significant effect on population health. Vaping of marijuana in the past 30 days, which typically involves high-potency concentrates, increased from 5% of 12th-grade students in 2017 to 14% in 2019, with 3.5% vaping near daily in 2019.10 The potential magnitude of mental health effects associated with the growing market of high-potency marijuana products is evidenced by estimates of the population-attributable fraction of first-episode psychosis due to use of high-potency marijuana (>10% tetrahydrocannabinol [THC]) at 12% (range, 1.9%-50.3%) in 11 primarily European cities studied, and by elevated risk for first-episode psychosis found in individuals using these products daily.11 Treatment data also suggest reason for concern. In 2014, marijuana was the leading drug used by clients entering drug treatment in a study of 22 European countries, representing 46% of all new clients, up from 29% in 2003.12 Both marijuana-related new clients and daily users in treatment more than doubled between 2003 and 2014.